BRM

BRISTOL-MYERS SQUIBBDL-10

Stock XETRA – Stock Market Prices, News & Analysis

Bristol-Myers Squibb est une entreprise pharmaceutique américaine spécialisée dans la recherche, le développement et la commercialisation de médicaments innovants principalement dans les domaines de l'oncologie, des maladies cardiovasculaires et de l'immunologie.

€ 49.55

0.56 %

Healthcare & Biotech Healthcare & Biotech News United States

BRISTOL-MYERS SQUIBBDL-10

€ 49.55

0.56 %

BRM

Pharmacie Immunologie Oncologie Recherche pharmaceutique Médicaments innovants

Healthcare & Biotech Healthcare & Biotech News United States

Price history of BRISTOL-MYERS SQUIBBDL-10

Performance & Momentum

6 Months 36.96 %

1 Year 22.58 %

3 Years 6.46 %

5 Years 19.15 %

Momentum

Unlock this indicator

Strategic Analysis

BRISTOL-MYERS SQUIBBDL-10 • 2026

Bristol-Myers Squibb positions itself as a major player in innovative pharmaceuticals, focused on high-value segments such as oncology, immunology, and cardiovascular diseases. Its ability to develop and commercialize innovative drugs enables it to maintain a strategic position in a highly competitive and regulated industry.

Strengths

Diversified portfolio centered on therapeutic themes with strong growth potential
Recognized expertise in pharmaceutical research and medical innovation
Strong positioning in innovative drugs that supports the resilience of the business model

Weaknesses

Volatile medium-term growth linked to dependence on new molecule launches
Sensitivity to strict regulations and pricing pressures in the pharmaceutical sector

Momentum

Current momentum points to a notable medium-term recovery, with positive performance over the last six months, although performance over a longer horizon remains mixed. The lack of recent news suggests a stabilization phase before potential opportunities linked to new clinical developments.

Ask our AI about BRISTOL-MYERS SQUIBBDL-10

Analysis performed 1 month ago